This part of the study is very interesting, IMO (under the heading "CBD effects and mechanisms of immune suppression in innate cells") :
"IL-6 is a proinflammatory cytokine produced by many cell types, predominantly innate cells. Many studies have shown that circulating IL-6 is readily inhibited by CBD in inflammatory models, including diabetes,124 asthma,127 pancreatitis,128 and hepatitis.86 CBD treatment in vivo resulted in lower IL-6 production in peritoneal macrophages stimulated ex vivo with LPS,124 in the pancreas in acute pancreatitis,128and in bronchoalveolar lavage fluid in LPS-induced pulmonary inflammation.125
(my emphasys)
LPS, lipopolysaccharide, are large molecules found in the outer membrane of Gram-negative bacteria, and on this forum it was posted that BOT has lodged patent applications for the use of CBD to treat those bugs.
Furthermore, the IL-6 receptor is the target of Tocilizumab (Actemra), Roche’s anti-inflammatory drug that's got the seal of approval from the Chinese National Health Commission’s new treatment guidelines for COVID-19 released earlier this week and now made available for free in Italy too following successful trials there:
http://www.ansa.it/english/news/science_tecnology/2020/03/11/coronavirusarthritis-drug-seems-to-work_8113f9d9-9bb8-4181-9c02-3e314c30e7e9.html
http://www.pmlive.com/pharma_news/china_backs_use_of_roches_actemra_for_coronavirus_1328014
...just joining the dots, not saying that BOT's CBD compounds can cure the virus, just a puzzling 'coincidence'....(?)
NOT FINANCIAL ADVICE
- Forums
- ASX - By Stock
- BOT
- Ann: Cowen Conference and Additional BTX 1503 Data Analysis
Ann: Cowen Conference and Additional BTX 1503 Data Analysis, page-64
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $354.4M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.0¢ | $2.251M | 9.851M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 355473 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 598121 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 350473 | 0.220 |
9 | 692274 | 0.215 |
10 | 294379 | 0.210 |
10 | 968025 | 0.205 |
16 | 1384994 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 4444 | 1 |
0.230 | 141575 | 5 |
0.235 | 260195 | 7 |
0.240 | 867464 | 5 |
0.245 | 383650 | 9 |
Last trade - 16.10pm 28/03/2024 (20 minute delay) ? |
|
|||||
Last
22.5¢ |
  |
Change
0.005 ( 2.27 %) |
|||
Open | High | Low | Volume | ||
22.5¢ | 24.0¢ | 22.0¢ | 4728143 | ||
Last updated 15.58pm 28/03/2024 ? |
Featured News
BOT (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online